Luminex Licensed Technologies Partner Spotlight:  EpiCypher

EpiCypher delivers high-quality reagents for epigenetics and chromatin research As one of Luminex’s Licensed Technologies Partners, EpiCypher is one of many companies that uses xMAP® Technology to deliver important solutions for improving research and molecular diagnostics. Based out of the Research Triangle Park in North Carolina, EpiCypher is a biotechnology company that helps scientists push […]

Read More…

For COVID-19 Detection and Epidemiology, xMAP® Technology Offers Unique Advantages

Multiplex serology tests have yielded impressive results, showing promise for use in the COVID-19 pandemic. xMAP-based serology tests have been widely implemented for the detection of pathogenic bacteria, viruses, and parasites. In the COVID-19 era, xMAP Technology has helped build several new multiplex serology tests designed to detect antibodies to different SARS-CoV-2 antigens. To demonstrate […]

Read More…

Webinar: Mount Sinai Scientists Design Multiplex COVID-19 Antibody Test

Implementing xMAP® Technology allows for faster, more accurate results When the global outbreak hit the US, the Icahn School of Medicine at Mount Sinai in New York City published some of the earliest COVID-19 studies in the US. It’s no surprise then that scientists at Mount Sinai were among the first to develop an antibody test. […]

Read More…

How to Reduce Coupling Variability with Luminex Bead Assays

Top 10 tips for a successful coupling process If you’re designing a new multiplex bead-based assay or adding new targets to an existing xMAP® Technology-based assay, the coupling process required to add a protein or an antibody can seem daunting. We’re here to help! While the Luminex custom assay development service can help you with […]

Read More…

xMAP® Technology Users Battle COVID-19 with New Serology Assays

Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. Our xMAP® Technology empowers researchers to build their own assays quickly, creatively, and effectively. Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. If you haven’t seen the […]

Read More…

Webinar: A Multiplex Serology Test for Detecting COVID-19 Antibodies in Dried Blood Spots

Rush University Medical Center develops a highly accurate test that can be used with dried blood spot samples. In a recent LabRoots webinar, Dr. Imad Tarhoni from Rush University Medical Center in Chicago offered a look at how his team developed a multiplex serological assay that they believe could be the cornerstone to a large-scale […]

Read More…

Precision Coupling with Molar Amounts of Protein

Precision coupling is useful for multiplex antibody assays, screening recombinant antibodies, and more! I’ve been getting a lot of requests lately to provide more information on the molar coupling method. If you’ve been wondering how it works, here’s a quick look at how to incorporate molar coupling into your assay development. When coupling whole immunoglobulins […]

Read More…

Coming Soon: A New Multiplex Serology Test for SARS-CoV-2

Luminex Partner Tetracore designed a serology assay for SARS-CoV-2 using xMAP® Technology. A new multiplex serology test to determine whether someone has been exposed to the SARS-CoV-2 virus is coming soon, thanks to assay developer Tetracore. The company—one of Luminex’s research partners—developed this test based on our xMAP Technology. We spoke with Tetracore Senior Scientist […]

Read More…

Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection

The novel coronavirus disease (COVID-19) pandemic continues to trigger rapid development of molecular diagnostic tests around the world. Nucleic acid amplification-based tests (NAATs)—such as real-time PCR and isothermal amplification—are the gold standard in molecular diagnostic technologies that are being utilized to detect SARS-CoV-2, the COVID-19 disease-causing virus.1 There are two critical and sequential steps that […]

Read More…

Questions to Ask When Choosing a Multiplex Assay Kit

With the COVID-19 pandemic in full swing, many researchers are looking to multiplex assays to evaluate what they call the “cytokine storm.” This refers to the increase in pro-inflammatory cytokines like IL-6 in patients with COVID-19, which is believed to predict disease severity.1 Many of Luminex’s Partners already have multiplex assays available for research use. […]

Read More…